Skip to main content

An Itemized List Of Colorful Things Coming To Light Ahead Of The Prince Jefri Bolkiah Trial


As you may have heard, the case Casa de Meadows, Inc. v. Zaman gets underway today. Prince Jefri of Brunei is suing two of his former advisers, claiming they screwed him out of millions while managing some of his assets. The former's attorneys have reportedly been trying to keep photos of six life-size bronze "erotic statues" created by artist J. Seward Johnson, which depict the Prince and his fiancée getting it on, out of the trial, over fears they might paint some sort of negative picture, prejudicing Jefri to a jury. Here are a few other items a narrow-mined jury might also take issue with:

* The Prince's alleged 40-girl harem (who were supposedly once told by an employee of the Prince, "You are whores, and I do not know why Boss paid so much money for you...You are the worst group of whores we have ever had over here.")

* His 17 children by 7 different women

* His yacht, which is named "Tits," and its tenders, which are named "Nipple 1" and "Nipple 2"

* If they have equally colorful names, such as Honkers, his 7,000 luxury cars (604 Rolls-Royces,574 Mercedes-Benzes, 452 Ferraris, 382 Bentleys, 179 Jaguars, and 21 Lamborghinis.)

Sex, Lies And Sultanates [NYM via Dealbook]
Prince of Brunei wants graphic sex statues of himself barred from New York courtroom [DM]


Who Wants To Help This Goal-Oriented List-Maker Cross A Few Items Off His Or Her To Do List?

"Go out w/ Wall Street guys" is an obvious one but there are a few others of which you could perhaps be of service.

Preet Bharara: University Of Michigan Doctor Financially Compensated For Leaking Confidential Drug Trial Data To Former SAC Trader Just An Innocent Pawn In Big Bad Hedge Fund's Game

As you may have heard, earlier today, Mathew Martoma, a former portfolio manager in SAC Capital's CR Intrinsic unit, was charged with allegedly running “the most lucrative insider trading scheme ever," netting $276 million for the fund. He did so based on information that was given to him by Sid Gilman, a University of Michigan neurologist and chair of a "safety-monitoring committee that oversaw a clinical trial by Wyeth LLC and Elan Corp.  into whether the drug bapineuzumab, or bapi, was safe for patients with mild-to-moderate Alzheimer’s disease." Over an 18-month period, Gilman and Martoma met 42 times, in addition to emailing and chatting over the phone. For example: